Company Profiles

driven by the PitchBook Platform

Telsar Pharma

Telsar Pharma
2012 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$14M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a drug for a common inflammatory bowel disease. The company was formed through the partnership of Astellas Pharma and Drais Pharmaceuticals to develop and commercialize an Astellas drug compound which is a melanocortin receptor agonist for the potential treatment of ulcerative olitis.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 520 US Highway 22
  • Suite 201
  • Bridgewater, NJ 08807
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Telsar Pharma’s full profile, request a free trial.

Telsar Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 25-Apr-2012 $14M 0000 000.00 Completed Clinical Trials - Phase 2
To view this company’s complete deal history including valuation and funding, request access »

Telsar Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
To view this company’s complete Cap Table, request access »

Telsar Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
InterWest Partners Venture Capital Minority 000 0000 000000 0
Sutter Hill Ventures Venture Capital Minority 000 0000 000000 0

Telsar Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Donna Tempel Ph.D President & Chief Executive Officer

Telsar Pharma Board Members (2)

Name Representing Role Since Contact
Info
Arnold Oronsky Ph.D InterWest Partners Board Member 000 0000
Jeffrey Bird Ph.D Sutter Hill Ventures Board Member 000 0000